[Effects of 1-4-dihydrazinophthalazine on urinary excretion of catecholamines, before and after administration of a beta-blocking drug. (Ciba 39089-Ba, a derivative of isopropylaminopropane)]. 1967

S Campus, and F Fabris, and A Rappelli, and I Mathis

UI MeSH Term Description Entries
D008297 Male Males
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

S Campus, and F Fabris, and A Rappelli, and I Mathis
March 1967, Bollettino della Societa italiana di biologia sperimentale,
S Campus, and F Fabris, and A Rappelli, and I Mathis
April 1971, The American journal of cardiology,
S Campus, and F Fabris, and A Rappelli, and I Mathis
July 1971, Indian heart journal,
S Campus, and F Fabris, and A Rappelli, and I Mathis
September 1969, Bollettino della Societa italiana di biologia sperimentale,
S Campus, and F Fabris, and A Rappelli, and I Mathis
April 1970, Bollettino della Societa italiana di biologia sperimentale,
S Campus, and F Fabris, and A Rappelli, and I Mathis
March 1968, The New Zealand medical journal,
S Campus, and F Fabris, and A Rappelli, and I Mathis
January 1970, Acta neurologica Scandinavica,
S Campus, and F Fabris, and A Rappelli, and I Mathis
October 1970, Arquivos brasileiros de cardiologia,
S Campus, and F Fabris, and A Rappelli, and I Mathis
November 1968, Acta medica Scandinavica,
Copied contents to your clipboard!